Home › Sjögren's Disease › Florida › Tampa
Sjögren's Disease clinical trials in Tampa, FL
4 studies for Sjögren's Disease are looking for participants at sites in and around Tampa (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
RecruitingPhase 2
- Clinical Research of West Florida Inc, Tampa
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
RecruitingPhase 3
- Clinical Research of West Florida Inc, Tampa
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
RecruitingPhase 3
- Finlay Medical Research Corp, Green Acres · 15 mi away
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
RecruitingPhase 3
- BayCare Medical Group Primary Care and Rheumatology - Tampa, Tampa
About Sjögren's Disease
Sjögren's disease is an autoimmune disease that causes dryness of the mouth, eyes, and other parts of the body. Learn how to relieve the symptoms.
More about Sjögren's Disease on MedlinePlus
Sjögren's Disease trials in other cities
- Washington, DC6 studies
- Houston, TX6 studies
- Boston, MA5 studies
- Clearwater, FL4 studies
- Cicero, IL4 studies
- Arlington, TX4 studies
- Charlotte, NC4 studies
- Oklahoma City, OK3 studies
- Memphis, TN3 studies
- Philadelphia, PA3 studies
- Chicago, IL3 studies
- Orlando, FL3 studies
Other studies in Tampa
- Non-Small Cell Lung Cancer53 studies
- Breast Cancer40 studies
- Cancer (all types)38 studies
- Colorectal Cancer36 studies
- Lung Cancer31 studies
- Metastatic Cancer30 studies
- Acute Myeloid Leukemia30 studies
- Pancreatic Cancer26 studies
- Melanoma21 studies
- Ovarian Cancer20 studies
- Alzheimer's Disease20 studies
- Myelodysplastic Syndromes20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.